NO176922C - Process for the preparation of bifunctional proteins - Google Patents

Process for the preparation of bifunctional proteins

Info

Publication number
NO176922C
NO176922C NO881658A NO881658A NO176922C NO 176922 C NO176922 C NO 176922C NO 881658 A NO881658 A NO 881658A NO 881658 A NO881658 A NO 881658A NO 176922 C NO176922 C NO 176922C
Authority
NO
Norway
Prior art keywords
preparation
bifunctional proteins
bifunctional
proteins
Prior art date
Application number
NO881658A
Other languages
Norwegian (no)
Other versions
NO881658D0 (en
NO881658L (en
NO176922B (en
Inventor
Paul Habermann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO881658D0 publication Critical patent/NO881658D0/en
Publication of NO881658L publication Critical patent/NO881658L/en
Publication of NO176922B publication Critical patent/NO176922B/en
Publication of NO176922C publication Critical patent/NO176922C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
NO881658A 1987-04-16 1988-04-15 Process for the preparation of bifunctional proteins NO176922C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873712985 DE3712985A1 (en) 1987-04-16 1987-04-16 BIFUNCTIONAL PROTEINS

Publications (4)

Publication Number Publication Date
NO881658D0 NO881658D0 (en) 1988-04-15
NO881658L NO881658L (en) 1988-10-17
NO176922B NO176922B (en) 1995-03-13
NO176922C true NO176922C (en) 1995-06-21

Family

ID=6325799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881658A NO176922C (en) 1987-04-16 1988-04-15 Process for the preparation of bifunctional proteins

Country Status (20)

Country Link
EP (1) EP0288809B1 (en)
JP (1) JP2667193B2 (en)
KR (1) KR970000187B1 (en)
AR (1) AR242991A1 (en)
AT (1) ATE79135T1 (en)
AU (1) AU613022B2 (en)
CA (1) CA1322157C (en)
DE (2) DE3712985A1 (en)
DK (1) DK170741B1 (en)
ES (1) ES2033981T3 (en)
FI (1) FI98830C (en)
GR (1) GR3006141T3 (en)
HU (1) HU204303B (en)
IE (1) IE61574B1 (en)
IL (1) IL86086A (en)
NO (1) NO176922C (en)
NZ (1) NZ224247A (en)
PH (1) PH25327A (en)
PT (1) PT87237B (en)
ZA (1) ZA882659B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5073627A (en) * 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
EP0489116B1 (en) * 1989-08-22 1994-04-06 Immunex Corporation Fusion proteins comprising gm-csf and il-3
US5108910A (en) * 1989-08-22 1992-04-28 Immunex Corporation DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
DK1037927T3 (en) 1997-12-08 2004-09-06 Emd Lexigen Res Ct Corp Heterodimeric fusion proteins useful for targeted immunotherapy and general immune stimulation
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
RU2263118C2 (en) 1999-08-09 2005-10-27 Лексиген Фармасьютикэлс Корп. Complexes of antibodies with some cytokines
JP4553290B2 (en) * 1999-11-30 2010-09-29 塩野義製薬株式会社 Chemokine SLC-IL2 fusion protein and its gene
AU4314801A (en) 2000-02-11 2001-08-20 Lexigen Pharm Corp Enhancing the circulating half-life of antibody-based fusion proteins
KR20090010127A (en) 2001-03-07 2009-01-28 메르크 파텐트 게엠베하 Expression technology for proteins containing a hybrid isotype antibody moiety
US6992174B2 (en) 2001-03-30 2006-01-31 Emd Lexigen Research Center Corp. Reducing the immunogenicity of fusion proteins
ATE502053T1 (en) 2001-05-03 2011-04-15 Merck Patent Gmbh RECOMBINANT TUMOR-SPECIFIC ANTIBODIES AND USE THEREOF
PT2279753E (en) 2001-10-10 2016-01-15 Novo Nordisk As Remodeling and glycoconjugation of peptides
US7186804B2 (en) 2001-12-04 2007-03-06 Emd Lexigen Research Center Corp. IL-2 fusion proteins with modulated selectivity
PT1572748E (en) 2002-12-17 2010-09-28 Merck Patent Gmbh Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
DK1944318T3 (en) * 2003-07-21 2011-06-14 Transgene Sa Multifunctional cytokines
DE602004031341D1 (en) 2003-07-21 2011-03-24 Transgene Sa MULTIFUNCTIONAL CYTOKINE
WO2010001414A1 (en) * 2008-07-03 2010-01-07 Lupin Limited Expression of heterologous proteins in bacterial system using a gm-csf fusion tag

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
EP0158198A1 (en) * 1984-03-29 1985-10-16 Takeda Chemical Industries, Ltd. DNA and use thereof
WO1985004673A1 (en) * 1984-04-10 1985-10-24 Takeda Chemical Industries, Ltd. Novel dna and its use
DE3419995A1 (en) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt GENE TECHNOLOGICAL METHOD FOR PRODUCING HUMAN INTERLEUKIN-2 AND MEANS FOR CARRYING OUT THIS METHOD
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
JPS61128889A (en) * 1984-11-27 1986-06-16 Green Cross Corp:The Recombinant dna and transformant by same
JPH0646957B2 (en) * 1985-03-11 1994-06-22 武田薬品工業株式会社 Method for producing interleukin-2
AU606585B2 (en) * 1985-10-03 1991-02-14 Biogen, Inc. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
DE3541856A1 (en) * 1985-11-27 1987-06-04 Hoechst Ag EUKARYOTIC FUSION PROTEINS, THEIR PRODUCTION AND USE, AND MEANS FOR CARRYING OUT THE PROCESS
DE3545568A1 (en) * 1985-12-21 1987-07-16 Hoechst Ag GM-CSF-PROTEIN, ITS DERIVATIVES, PRODUCTION OF SUCH PROTEINS AND THEIR USE

Also Published As

Publication number Publication date
DK209188D0 (en) 1988-04-15
JPS63301898A (en) 1988-12-08
PT87237A (en) 1988-05-01
AR242991A1 (en) 1993-06-30
AU1466188A (en) 1988-10-20
NO881658D0 (en) 1988-04-15
DK209188A (en) 1988-10-17
KR880012760A (en) 1988-11-29
DK170741B1 (en) 1996-01-08
IE881146L (en) 1988-10-16
DE3873397D1 (en) 1992-09-10
FI98830B (en) 1997-05-15
EP0288809B1 (en) 1992-08-05
FI881743A0 (en) 1988-04-14
ES2033981T3 (en) 1993-04-01
NO881658L (en) 1988-10-17
IL86086A (en) 1995-01-24
PT87237B (en) 1992-07-31
CA1322157C (en) 1993-09-14
DE3712985A1 (en) 1988-11-03
EP0288809A1 (en) 1988-11-02
NO176922B (en) 1995-03-13
GR3006141T3 (en) 1993-06-21
PH25327A (en) 1991-04-30
HU204303B (en) 1991-12-30
NZ224247A (en) 1990-04-26
FI98830C (en) 1997-08-25
IE61574B1 (en) 1994-11-16
AU613022B2 (en) 1991-07-25
ATE79135T1 (en) 1992-08-15
HUT47319A (en) 1989-02-28
KR970000187B1 (en) 1997-01-06
ZA882659B (en) 1988-10-14
IL86086A0 (en) 1988-09-30
JP2667193B2 (en) 1997-10-27
FI881743A (en) 1988-10-17

Similar Documents

Publication Publication Date Title
NO176922C (en) Process for the preparation of bifunctional proteins
PT86600A (en) PROCESS FOR THE PREPARATION OF ANTICOAGULANT PEPTIDES
NO173498C (en) Analogous procedure for the preparation of substituted 9-amino-tetrahydroacridines
NO844710L (en) PROCEDURE FOR THE PREPARATION OF HIGH PROTEIN
PT86687A (en) PROCESS FOR THE PREPARATION OF NOVEL POLYAMINE DERIVATIVES
NO172447C (en) PROCEDURE FOR B-AVERMECTIN PREPARATION
FI881303A (en) Process for the preparation of ibuprofen
FI91961C (en) Process for the preparation of (S) -ethyl-2-oxo-1-pyrrolidineacetamide
PT87857A (en) PROCESS FOR THE PREPARATION OF NOVEL IMMUNOSSUPRESSANT PEPTIDES
NO880294D0 (en) PROCEDURE FOR THE PREPARATION OF TETRAHYDROFURAND DERIVATIVES
PT86960A (en) PROCESS FOR THE PREPARATION OF IMMUNOGLOBULIN CONJUGATES
NO882730D0 (en) PROCEDURE FOR THE PREPARATION OF AMINOCYCLOPENTYLETERS.
NO885002D0 (en) PROCEDURE FOR THE PREPARATION OF SIALOCYL GLYCEROLIPIDES.
NO174085C (en) Process for the preparation of sucralfate preparations
FI91069B (en) Process for the preparation of 5-C-hydroxymethylaldhexose-based compounds
PT87732A (en) PROCESS FOR THE PREPARATION OF (E) - (P-FLUOROPHENETHYL) -3-FLUOROALLYLAMINE
NO885446D0 (en) PROCEDURE FOR THE PREPARATION OF QUINOLINCARBOXYLIC ACIDS.
NO880834D0 (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLYL-2-PROPYN-1-AMINES.
NO174745C (en) Process for the preparation of cycloalkadienes
NO170095C (en) PROCEDURE FOR THE PREPARATION OF LIGNOCELLULOS MATERIAL PRODUCTS
NO960829D0 (en) Process for the preparation of 13-alkyl-11r
SE8801744D0 (en) PROCEDURE FOR THE PREPARATION OF DITIONITE
NO168583C (en) PROCEDURE FOR THE PREPARATION OF BENZOXADIAZOLD DERIVATIVES
IT8748557A0 (en) PROCEDURE FOR THE PREPARATION OF PRIRIDOBENZODIAZEPINONE
NO940861L (en) Process for the preparation of substituted 2-aminoteralins

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2003